Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced the Orphan Drug Designation of its cystic fibrosis therapy by the Food and Drug Administration (FDA). On February 10 ...

CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Although recent advancements in CFTR modulator therapies have improved outcomes for many people ...

This can include many kinds of lung conditions, such as asthma, bronchitis, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and others. University of Utah Health Pulmonary Services ...

Cystic fibrosis (CF) is a genetic condition that affects the lungs, pancreas and other organs, caused by variations on the cystic fibrosis transmembrane conductance regulator  (CFTR) gene. There are ...